Altruist Biologics' Hangzhou Facility Achieves Milestone with First Commercial License Altruist Biologics has achieved a significant milestone by securing its first commercial manufacturing license for its Hangzhou facility in China.

Altruist Biologics' Hangzhou Facility Achieves Milestone with First Commercial License #China #Hangzhou #Innovent_Biologics #NMPA #Altruist_Biologics

Altruist Biologics Achieves Milestone with First GMP Manufacturing License in China Altruist Biologics' Hangzhou facility has successfully received the first Drug Product Manufacturing License in China, marking a significant advancement in biomanufacturing capabilities.

Altruist Biologics Achieves Milestone with First GMP Manufacturing License in China #China #Hangzhou #CDMO #Altruist_Biologics

Altruist Biologics Unveils Altru-CON™ Platform to Speed Up Biologics Development Altruist Biologics has introduced Altru-CON™, a new high-concentration formulation platform aimed at accelerating biologics development and commercialization. This innovative technology enables enhanced drug delivery and stability.

Altruist Biologics Unveils Altru-CON™ Platform to Speed Up Biologics Development #China #Suzhou #Biologics_Development #Altruist_Biologics #Altru-CON™